Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor Full Text
The Oncologist, 02/28/2012
Macfarlane R et al. – A significant proportion of relapsed tumors had changes in either estrogen receptor (ER) or human epidermal growth factor receptor (HER)–2 status, which would dramatically alter treatment recommendations and clinical behavior. This study suggests that biopsies of relapsed and metastatic breast cancers should be performed routinely in clinical practice.
